JYSZ2400046 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | License Renew | 2024-07-18 | | GlaxoSmithKline Biologicals SA | | | view |
JYSZ2400045 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | License Renew | 2024-07-18 | | GlaxoSmithKline Biologicals SA | | | view |
CYSB2300231 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2023-12-09 | | Shenzhen Kangtai Biological Products Co Ltd | | | view |
CYSB2300074 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2023-03-30 | | Shenzhen Kangtai Biological Products Co Ltd | | | view |
JYSB2300037 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2023-02-23 | | GlaxoSmithKline Biologicals SA | | | view |
JYSB2300038 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2023-02-23 | | GlaxoSmithKline Biologicals SA | | | view |
CYSB2300038 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2023-02-13 | | Beijing Institute of Biological Products Co Ltd | | | view |
CYSB2300040 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2023-02-13 | | Beijing Institute of Biological Products Co Ltd | | | view |
CYSB2300039 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2023-02-13 | | Beijing Institute of Biological Products Co Ltd | | | view |
JYSB2300006 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2023-01-14 | | GlaxoSmithKline Biologicals SA | | | view |
JYSB2300007 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2023-01-14 | | GlaxoSmithKline Biologicals SA | | | view |
JYSB2200113 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2022-07-02 | | GlaxoSmithKline Biologicals SA | | | view |
JYSB2200112 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2022-07-02 | | GlaxoSmithKline Biologicals SA | | | view |
JYSB2101077 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-07-05 | | GlaxoSmithKline Biologicals SA | | | view |
JYSB2101078 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-07-05 | | GlaxoSmithKline Biologicals SA | | | view |
JYSB2101075 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-07-02 | | GlaxoSmithKline Biologicals SA | | | view |
JYSB2101076 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-07-02 | | GlaxoSmithKline Biologicals SA | | | view |
JYSB2100055 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-02-23 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-22 | view |
JYSB2100054 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-02-23 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-22 | view |
JYSB2100057 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2021-02-23 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-22 | view |